SG11202013235YA - Cannabinoid composition and method for treating ptsd and/or anxiety - Google Patents

Cannabinoid composition and method for treating ptsd and/or anxiety

Info

Publication number
SG11202013235YA
SG11202013235YA SG11202013235YA SG11202013235YA SG11202013235YA SG 11202013235Y A SG11202013235Y A SG 11202013235YA SG 11202013235Y A SG11202013235Y A SG 11202013235YA SG 11202013235Y A SG11202013235Y A SG 11202013235YA SG 11202013235Y A SG11202013235Y A SG 11202013235YA
Authority
SG
Singapore
Prior art keywords
anxiety
cannabinoid composition
treating ptsd
ptsd
treating
Prior art date
Application number
SG11202013235YA
Inventor
Harry Karelis
Original Assignee
Zelira Therapeutics Operations Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zelira Therapeutics Operations Pty Ltd filed Critical Zelira Therapeutics Operations Pty Ltd
Publication of SG11202013235YA publication Critical patent/SG11202013235YA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/658Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/01Hydrocarbons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/01Hydrocarbons
    • A61K31/015Hydrocarbons carbocyclic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/348Cannabaceae
    • A61K36/3482Cannabis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
SG11202013235YA 2018-07-03 2019-07-03 Cannabinoid composition and method for treating ptsd and/or anxiety SG11202013235YA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2018100925A AU2018100925A4 (en) 2018-07-03 2018-07-03 Cannabinoid composition and method for treating PTSD and/or anxiety
PCT/AU2019/050698 WO2020006597A1 (en) 2018-07-03 2019-07-03 Cannabinoid composition and method for treating ptsd and/or anxiety

Publications (1)

Publication Number Publication Date
SG11202013235YA true SG11202013235YA (en) 2021-01-28

Family

ID=63079634

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202013235YA SG11202013235YA (en) 2018-07-03 2019-07-03 Cannabinoid composition and method for treating ptsd and/or anxiety

Country Status (13)

Country Link
US (1) US20210308092A1 (en)
EP (1) EP3817735A4 (en)
KR (1) KR20210071940A (en)
AU (2) AU2018100925A4 (en)
BR (1) BR112020027060A2 (en)
CA (1) CA3104739A1 (en)
CL (1) CL2020003374A1 (en)
CO (1) CO2021001059A2 (en)
IL (1) IL279799A (en)
MX (1) MX2021000024A (en)
PE (1) PE20210974A1 (en)
SG (1) SG11202013235YA (en)
WO (1) WO2020006597A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020168073A1 (en) * 2019-02-13 2020-08-20 Caras Jim Composition comprising hydrolyzed collagen and cannabidiol and use thereof
CN110433133A (en) * 2019-08-19 2019-11-12 中国人民解放军军事科学院军事医学研究院 The cannabidiol nasal formulations for treating posttraumatic stress disorder
US20240358726A1 (en) * 2021-09-03 2024-10-31 Yale University Specific therapeutic medical marijuana doses for stress and pain

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2895805A1 (en) * 2012-12-18 2014-06-26 Kotzker Consulting Llc Use of cannabinoids and terpenes for treatment of organophosphate and carbamate toxicity
BR122021018502B1 (en) * 2014-10-21 2022-05-03 United Cannabis Corp Liquid cannabinoid formulation
CA2952335A1 (en) * 2015-12-19 2017-06-19 Delta 9 Gardening B.V. Therapeutic delivery formulations and systems comprising cannabinoids and terpenes
PT3429580T (en) * 2016-03-16 2025-08-12 Buzzelet Development And Technologies Ltd Terpene-enriched cannabinoid composition
WO2018222923A1 (en) * 2017-05-31 2018-12-06 Phytecs, Inc. Pharmaceutical compositions comprising cannabidiol and beta-caryophyllene and methods for their use
WO2019089583A1 (en) * 2017-10-30 2019-05-09 Endocanna Health, Inc. Cannabinoid formulations

Also Published As

Publication number Publication date
IL279799A (en) 2021-03-01
AU2018100925A4 (en) 2018-08-09
EP3817735A4 (en) 2022-03-23
BR112020027060A2 (en) 2021-03-30
CO2021001059A2 (en) 2021-06-30
MX2021000024A (en) 2021-05-27
WO2020006597A1 (en) 2020-01-09
CA3104739A1 (en) 2020-01-09
CL2020003374A1 (en) 2021-08-13
US20210308092A1 (en) 2021-10-07
EP3817735A1 (en) 2021-05-12
AU2019297196A1 (en) 2021-01-28
PE20210974A1 (en) 2021-05-25
KR20210071940A (en) 2021-06-16

Similar Documents

Publication Publication Date Title
IL272627A (en) Terpene-enriched cannabinoid composition and method of treatment
EP3869985A4 (en) COMPOSITION AND METHOD FOR TREATING THE LUNGS
SG11202002169TA (en) Composition and method for treating autism
SG11202002874VA (en) Method, apparatus, and computer-readable medium for compliance aware tokenization and control of asset value
GB2571431B (en) Electronic apparatus and method for controlling the same
PT3785682T (en) Cooling apparatus and cooling method
IL251215A0 (en) Cannabinoid composition and method for treating pain
ZA202000245B (en) Method and apparatus for pasteurizing and dehydrating marijuana
SG10201709324XA (en) Apparatus for treatment of waste gas and method for treating the same
GB201700105D0 (en) Aftertreatment temperature control apparatus and method
GB201819415D0 (en) Microfluidic apparatus and method
EP4061993A4 (en) LAUNDRY TREATMENT APPARATUS AND METHOD FOR CONTROLLING THE LAUNDRY TREATMENT APPARATUS
SG11202012055PA (en) Methods and compositions for preventing or treating calciphylaxis
SG10201706291TA (en) Composition And Method For Treating Skin Conditions
EP3660425C0 (en) COOLING SYSTEM AND CONTROL METHOD FOR IT
IL267988B1 (en) Method and apparatus for heating and purifying liquids
SG11202013235YA (en) Cannabinoid composition and method for treating ptsd and/or anxiety
GB201903038D0 (en) Ophthalmologic apparatus and method of controlling the same
ZA202005720B (en) Method for treating asthma or allergic disease
ZA201904853B (en) Demulsification additive composition, use thereof, and method of demulsification
GB201912645D0 (en) Electronic apparatus and method for controlling the same
IL281151A (en) Hardening method and apparatus, particularly applicable to metal and/or ceramics
GB201815262D0 (en) Composition and method
EP3862709C0 (en) REFRIGERATOR AND METHOD FOR CONTROLLING THE SAME
HUE068710T2 (en) Nk1-antagonist combination and method for treating synucleinopathies